Semaglutide for obesity in adults: PRISMA-lite example
A sample structure showing how LitSynth can organize a biomedical question into screened evidence, synthesis sections, and explicit review limits.
Current product strategy is login-first; public pages show the workflow and examples before opening the workspace.
Search intent
semaglutide obesity systematic review
Biomedical researchers evaluating how LitSynth handles clinical evidence workflows.
high-demand biomedical review example
sample output mirrors real review structure
clinical interpretation remains human-led
What it does
Show the shape of a review output before users enter the logged-in workspace.
Frame the clinical question and evidence scope.
Document title and abstract screening assumptions.
Separate efficacy, safety, and durability findings.
Surface citation audit notes before export.
Workflow
From question to auditable draft
- 1
Define the obesity treatment question.
- 2
Retrieve GLP-1 receptor agonist studies and reviews.
- 3
Screen for adult obesity relevance.
- 4
Draft a PRISMA-lite synthesis with caveats.
Example snapshot
What does current evidence suggest about semaglutide for weight loss in adults with obesity?
Included evidence
- Randomized clinical trials evaluating semaglutide dose and weight outcomes.
- Safety analyses covering gastrointestinal adverse events and discontinuation.
- Longer-term follow-up studies on maintenance and regain after treatment changes.
Output sections
- Background and rationale
- Search and screening snapshot
- Efficacy findings
- Safety and tolerability
- Evidence limitations
Audit note
Claims about clinical benefit should be verified against trial populations, endpoints, and follow-up duration.
Continue in the workspace
Login first, then open Review with this research question already attached.
Public report preview
What a real LitSynth output should reveal
The preview exposes the report structure, screening counts, evidence rows, citation audit score, and export outline before users enter the private workspace.
Abstract
This public preview illustrates how LitSynth structures a PRISMA-lite review on semaglutide for adults with obesity. The report separates search and screening assumptions from synthesis claims, groups findings into efficacy, safety, and durability sections, and marks clinical statements that require original-paper verification before use. It is intentionally presented as a review preview, not medical advice or a completed systematic review.
Search strategy
- Natural-language question expanded into semaglutide, obesity, weight loss, adults, GLP-1 receptor agonist, randomized trial, and safety terms.
- Candidate records are screened at title and abstract level before inclusion in the public synthesis preview.
- The preview labels full-text appraisal, protocol registration, and meta-analysis as outside this example.
Evidence table
A public preview of the kind of structured evidence users inspect before trusting a generated synthesis.
| Citation | Study type | Population | Sample | Finding | Support |
|---|---|---|---|---|---|
| STEP-style randomized trial evidence | Randomized controlled trial | Adults with overweight or obesity | Large multicenter trial population | Semaglutide groups reported greater mean weight reduction than lifestyle-only comparators. | Strong |
| Safety and tolerability analysis | Trial safety analysis | Adults receiving GLP-1 receptor agonist therapy | Pooled adverse event observations | Gastrointestinal adverse events are prominent and discontinuation context should be reported. | Moderate |
| Weight maintenance follow-up | Follow-up study | Adults after treatment continuation or withdrawal | Longer follow-up cohort | Durability claims depend on treatment continuation, follow-up duration, and behavioral support. | Needs review |
Citation audit
Efficacy statements are well supported in this preview; durability and comparative safety claims require closer source inspection.
Export preview
- 1Title and abstract
- 2PRISMA-lite search and screening snapshot
- 3Evidence table
- 4Efficacy synthesis
- 5Safety and tolerability synthesis
- 6Citation audit notes
Use this example as a live starting point
The public preview stays indexable, while the actual search, screening, synthesis, and export flow remains inside the logged-in Review workspace.
Boundaries
Clear claims matter for research tools
- This example is illustrative and not medical advice.
- Formal clinical reviews require protocol registration and full-text appraisal.
- Effect sizes and safety conclusions must be verified from original papers.
FAQ
Is this a completed medical systematic review?
No. It is an example of the page structure and workflow LitSynth can support for biomedical evidence synthesis.
Why use semaglutide as an example?
It is a familiar biomedical topic with strong search demand and clear evidence dimensions: efficacy, safety, durability, and patient selection.
Can users generate similar examples?
Yes. Logged-in users can search papers, screen evidence, and generate literature review or Systematic Review Beta drafts.
Build your own review from selected papers
Search, screen, synthesize, and audit in the logged-in LitSynth workspace.